These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31382181)

  • 21. Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China.
    Dong H; Yang M; Liu L; Zhang C; Liu M; Shen Y; Liu H; Hao W
    BMC Psychiatry; 2017 May; 17(1):183. PubMed ID: 28499448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood trauma and METH abuse among men who have sex with men: Implications for intervention.
    Lopez-Patton M; Kumar M; Jones D; Fonseca M; Kumar AM; Nemeroff CB
    J Psychiatr Res; 2016 Jan; 72():1-5. PubMed ID: 26519763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
    Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R;
    J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contingency management for the treatment of methamphetamine use disorders.
    Roll JM; Petry NM; Stitzer ML; Brecht ML; Peirce JM; McCann MJ; Blaine J; MacDonald M; DiMaria J; Lucero L; Kellogg S
    Am J Psychiatry; 2006 Nov; 163(11):1993-9. PubMed ID: 17074952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
    Lea T; Kolstee J; Lambert S; Ness R; Hannan S; Holt M
    PLoS One; 2017; 12(2):e0172560. PubMed ID: 28207902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving Rehabilitative Care of Methamphetamine Users in Germany: The Expert's Perspective.
    Hoffmann L; Buchenauer L; Schumann N; Schröder SL; Martin O; Richter M
    Qual Health Res; 2019 Jan; 29(2):248-259. PubMed ID: 30129874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact.
    McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI
    Drug Alcohol Rev; 2018 Feb; 37(2):196-204. PubMed ID: 28294443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
    Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
    Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of methamphetamine-associated socioeconomic status and addictive behaviors, and their impact on oral health.
    Rommel N; Rohleder NH; Wagenpfeil S; Haertel-Petri R; Kesting MR
    Addict Behav; 2015 Nov; 50():182-7. PubMed ID: 26151583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
    Wallace C; Galloway T; McKetin R; Kelly E; Leary J
    Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary and substance-induced psychotic disorders in methamphetamine users.
    Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse antecedents for methamphetamine use and related factors in Taiwanese adolescents.
    Yen CF; Chang YP
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):77-82. PubMed ID: 15679544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: an emerging profile.
    von MC; Brecht ML; Anglin MD
    J Addict Dis; 2002; 21(1):45-60. PubMed ID: 11831499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental Health and Substance Use Disorder Comorbidity among Methamphetamine-Using Men Who have Sex with Men.
    Fletcher JB; Swendeman D; Reback CJ
    J Psychoactive Drugs; 2018; 50(3):206-213. PubMed ID: 29608132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of depression on treatment for methamphetamine use.
    Kay-Lambkin FJ; Baker AL; Lee NM; Jenner L; Lewin TJ
    Med J Aust; 2011 Aug; 195(3):S38-43. PubMed ID: 21806517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia.
    Kessler T; Lev-Ran S
    Compr Psychiatry; 2019 Feb; 89():7-15. PubMed ID: 30557808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine dependence treatment rehabilitation in Thailand: a model assessment.
    Perngparn U; Limanonda B; Aramrattana A; Pilley C; Areesantichai C; Taneepanichskul S
    J Med Assoc Thai; 2011 Jan; 94(1):110-7. PubMed ID: 21425736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status of methamphetamine users 2-5 years after outpatient treatment.
    Rawson RA; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
    J Addict Dis; 2002; 21(1):107-19. PubMed ID: 11831496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.